Halothane hepatitis. Possibilities of prevention
Døssing, M.; Andreasen, B.; Ranek, L.; Johansen, S.H.
Ugeskrift for Laeger 144(7): 466-468
1982
ISSN/ISBN: 0041-5782 PMID: 7080249 Document Number: 187576
Document emailed within 1 workday
Related Documents
Moerman, N.; Porcelijn, T.; Deen, L. 1979: Halothane hepatitis Nederlands Tijdschrift Voor Geneeskunde 123(20): 853-855Sherlock, S. 1978: Halothane hepatitis Lancet 2(8085): 364-365
Fehér, J.; Vásárhelyi, B.; Blázovics, A. 1993: Halothane hepatitis Orvosi Hetilap 134(33): 1795-1798
Kreienbühl, G. 1981: "Hepatitis" following halothane-anesthesia Der Anaesthesist 30(1): 1-10
Stalnikiewicz, G.; Rambaux, P.; Leroy, M.; Watrisse, G.; Saudemont, M.; Dujardin, J.J. 1977: Hepatitis after halothane anesthesia Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 22(10): 771-773
Shipton, E.A.; Kruger, A.E. 1984: Halothane hepatitis and the anaesthesiologist South African Medical Journal 65(3): 86-89
Peralma, A.; Touron, J.L. 1989: A case of fulminant hepatitis due to halothane Cahiers d'Anesthesiologie 37(4): 295-297
Carney, F.M.; Van Dyke, R.A. 1972: Halothane hepatitis: a critical review Anesthesia and Analgesia 51(1): 135-160
Christensen, J.; Hjortsø, E. 1980: Halothane hepatitis--increased incidence? Ugeskrift for Laeger 142(9): 574-576
Reves, J.G. 1974: Halothane hepatitis. Current concepts Postgraduate Medicine 56(4): 65-70
Chapman, B.A.; Laurenson, V.G.; Cook, H.B. 1985: Halothane hepatitis: toxicity or hypersensitivity? New Zealand Medical Journal 98(787): 793-796
Owen, D.R.; Schenken, J.R. 1972: Halothane hepatitis--an unsettled issue Nebraska Medical Journal 57(10): 405-409
Daghfous, R.; el Aïdli, S.; Sfaxi, M.; Daghfous, M.; Kastalli, S.; Sraïri, S.; Loueslati, M.Hédi.; Belkahia, C. 2003: Halothane-induced hepatitis. 8 case reports La Tunisie Medicale 81(11): 874-878
Lee, S.C.; Yamamoto, G.; Chueh, C.H.; Lin, K.J.; Lin, Y.S.; Shong, K.L.; Wang, M.H.; Amano, S. 1988: Unexplained hepatitis following reexposure to halothane at 10-year interval Ma Zui Xue Za Zhi 26(3): 329-334
Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616
Giorgini, R.J.; Giorgini, G.L.; Lombardo, M. 1982: Halothane hepatitis: a series of case report following podiatric surgery Journal of Foot Surgery 21(3): 170-173
Hehre, F.W.; Pschirrer, A.R.; Mason, B.; Davidson, D. 1974: Anesthesiology grand rounds. Yale-New Haven hospital: "Halothane Hepatitis" Connecticut Medicine 38(4): 162-164
Windsor, J.A.; Wynne-Jones, G. 1988: Halothane hepatitis and prompt resolution with methionine therapy: case report New Zealand Medical Journal 101(851): 502-503
Goto, T.; Ohwan, K.; Matsumoto, N.; Miyazaki, T.; Murakami, Y.; Ohhata, M.; Hori, T.; Shiota, K. 1990: Protective effect of calcium channel blockers on the liver against halothane hepatitis in rats Masui. Japanese Journal of Anesthesiology 39(2): 204-209
Hutters, L.; Andreasen, P.B. 1978: Toxic hepatitis after halothane. 98 cases reported to the Danish Board on Adverse Reactions to Drugs Ugeskrift for Laeger 140(14): 798-799